Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 3/20 | 0.53 |
| ▸ | TACR1 | P25103 | 2/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.53 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.53 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.52 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | CTSS | P25774 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | TDO2 | P48775 | 1/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5701914 | 1.00 | PPARA (0.54) | PPARAPPARGCTSKTACR1FOLH1 | |
| SCHEMBL19520868 | 0.92 | FOLH1 (0.57) | PPARAPPARGCTSKTACR1FOLH1 | |
| SCHEMBL4141813 | 0.92 | FOLH1 (0.57) | PPARAPPARGCTSKTACR1FOLH1 | |
| SCHEMBL2064380 | 0.91 | CTSK (0.53) | CTSKTACR1CTRB1CTSLCTSB | |
| SCHEMBL2064382 | 0.91 | CTSK (0.53) | CTSKTACR1CTRB1CTSLCTSB | |
| SCHEMBL1111096 | 0.89 | KYNU (0.60) | CTSKTACR1SIRT2SIRT1CTRB1 | |
| SCHEMBL1111168 | 0.89 | KYNU (0.60) | CTSKTACR1SIRT2SIRT1CTRB1 | |
| SCHEMBL1111092 | 0.89 | KYNU (0.60) | CTSKTACR1SIRT2SIRT1CTRB1 | |
| SCHEMBL29383012 | 0.89 | KYNU (0.60) | CTSKTACR1SIRT2SIRT1CTRB1 | |
| SCHEMBL8387978 | 0.88 | FOLH1 (0.65) | PPARAPPARGCTSKFOLH1SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117624011-A | Preparation method of L-pyroglutamic acid-14C | 长沙贝塔医药科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-113453554-B | herbicidal composition | 先正达农作物保护股份公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-111032640-B | Herbicidal compounds | 先正达参股股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| EP-3923724-B1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-07-26 | — | — | EP | disclosed |
| US-11618743-B2 | Herbicidal compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2023-04-04 | — | — | US | disclosed |
| US-20220192195-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2022-06-23 | — | — | US | disclosed |
| US-20220159956-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2022-05-26 | — | — | US | disclosed |
| US-20220142162-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2022-05-12 | — | — | US | disclosed |
| US-20220125052-A1 | Herbicidal Compositions | SYNGENTA CROP PROTECTION AG (CH) | 2022-04-28 | — | — | US | disclosed |
| US-20220125051-A1 | PRE-HARVEST DESICCATION METHOD | SYNGENTA CROP PROTECTION AG (CH) | 2022-04-28 | — | — | US | disclosed |
| WO-2020164925-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2020-08-20 | — | — | WO | disclosed |
| WO-2020164971-A1 | PRE-HARVEST DESICCATION METHOD | SYNGENTA CROP PROTECTION AG (CH) | 2020-08-20 | — | — | WO | disclosed |
| WO-2020164920-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2020-08-20 | — | — | WO | disclosed |
| EP-3668855-A1 | HERBICIDAL COMPOUNDS | Syngenta Participations AG (CH) | 2020-06-24 | — | — | EP | disclosed |
| WO-2019034757-A1 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-02-21 | — | — | WO | disclosed |
| US-20100216802-A1 | PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER | CHROMA THERAPEUTICS LTD. (GB) | 2010-08-26 | — | — | US | disclosed |
| US-20090203711-A1 | Inhibitors of P38 Map Kinase | CHROMA THERAPEUTICS LTD. (GB) | 2009-08-13 | — | — | US | disclosed |
| EP-2079743-A1 | PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER | Chroma Therapeutics Limited (GB) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008053157-A1 | AMINOHETEROARYL COMPOUNDS AS FOR THE TREATMENT OF DISEASES MEDIATED BY C-MET KINASE ACTIVITY | CHROMA THERAPEUTICS LTD. (GB) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008050096-A1 | PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER | CHROMA THERAPEUTICS LTD. (GB) | 2008-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220142162-A1 | HERBICIDAL COMPOSITIONS | PPOX, DDT, HPD | PPARA 962/4885PPARG 775/4885CTSK 2658/4885 |
| US-20220159956-A1 | HERBICIDAL COMPOSITIONS | DDT, HPD, DHFR | PPARA 555/4885PPARG 351/4885CTSK 2985/4885 |
| US-20090203711-A1 | Inhibitors of P38 Map Kinase | MAPK1, MAPK3, CNKSR1 | PPARA 2557/4885PPARG 1754/4885CTSK 1291/4885 |
| US-11618743-B2 | Herbicidal compounds | DDT, ACHE, GSTO1 | PPARA 367/4885PPARG 180/4885CTSK 2004/4885 |
| US-20220125052-A1 | Herbicidal Compositions | DDT, HPD, DHFR | PPARA 593/4885PPARG 520/4885CTSK 3260/4885 |
| US-20220125051-A1 | PRE-HARVEST DESICCATION METHOD | GMDS, TREH, DAD1 | PPARA 2979/4885PPARG 2232/4885CTSK 2122/4885 |
| US-20220192195-A1 | HERBICIDAL COMPOSITIONS | GLO1, LCT, HACL2 | PPARA 2247/4885PPARG 1843/4885CTSK 1377/4885 |
| US-20100216802-A1 | PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER | PLK2, PLK4, PLK3 | PPARA 2353/4885PPARG 3299/4885CTSK 983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.